China’s Sovereign Fund to Acquire $40 Million Stake in iKang

The China Investment Corporation (CIC) is acquiring a 40% stake in iKang Healthcare Group Inc for US$ 40 million through Best Investment Corporation. Beijing-based iKang is a private healthcare provider that focuses on preventative care. The CIC is purchasing the shares at the initial public offering price.

iKang is looking to raise around US$ 150 million in its IPO on the Nasdaq. Bank of America Merrill Lynch and UBS AG are in charge of the share sale.

On April 12, 2013, GIC Private Limited and Goldman Sachs invested US$ 100 million into iKang.



Contact the writer or creator of this article or page.
Questions or comments: support(at)swfinstitute(dot)org
Follow on Twitter at @swfinstitute and @sovereignfunds
Learn, Attend and Network: Institutional Investor Events and Summits
Go Back: HOME: Sovereign Wealth Fund Institute


 
institutional investor investment mandates